Incyte (INCY) News Today $84.26 -0.47 (-0.55%) As of 12:12 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INCY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Promising Efficacy and Safety of Incyte’s Oncology Assets Justify Buy RatingOctober 14 at 6:11 AM | tipranks.comCallan Family Office LLC Makes New Investment in Incyte Corporation $INCYOctober 14 at 3:44 AM | marketbeat.comIncyte Corp. stock rises Monday, still underperforms marketOctober 13 at 10:09 PM | marketwatch.comIncyte announces results from its Phase 1 studies of INCA33890, INCB161734October 13 at 7:05 AM | msn.comData from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 2025October 13 at 7:05 AM | finance.yahoo.comData from Incyte's TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 2025October 12 at 6:05 PM | businesswire.comwaypoint wealth counsel Purchases New Shares in Incyte Corporation $INCYOctober 12 at 5:20 AM | marketbeat.comCommerzbank Aktiengesellschaft FI Invests $211,000 in Incyte Corporation $INCYOctober 12 at 4:09 AM | marketbeat.comBelpointe Asset Management LLC Takes Position in Incyte Corporation $INCYOctober 12 at 3:32 AM | marketbeat.comShikiar Asset Management Inc. Has $7.76 Million Stock Holdings in Incyte Corporation $INCYOctober 11 at 6:56 AM | marketbeat.comJP Morgan Maintains Incyte (INCY) Neutral RecommendationOctober 10, 2025 | msn.comWhat 14 Analyst Ratings Have To Say About IncyteOctober 10, 2025 | benzinga.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for Incyte (NASDAQ:INCY) StockOctober 10, 2025 | marketbeat.comKLP Kapitalforvaltning AS Has $8.97 Million Stock Position in Incyte Corporation $INCYOctober 10, 2025 | marketbeat.comIncyte (NASDAQ:INCY) Given Hold (C+) Rating at Weiss RatingsOctober 9, 2025 | marketbeat.comIncyte Corporation $INCY Shares Purchased by Shell Asset Management Co.October 9, 2025 | marketbeat.comIncyte Corp. stock underperforms Wednesday when compared to competitorsOctober 8, 2025 | marketwatch.comIncyte downgraded to Perform from Outperform at OppenheimerOctober 8, 2025 | msn.comIncyte downgraded to Perform from Outperform at OppenheimerOctober 8, 2025 | msn.comIncyte to Report Third Quarter Financial ResultsOctober 8, 2025 | finance.yahoo.comHB Wealth Management LLC Makes New Investment in Incyte Corporation $INCYOctober 8, 2025 | marketbeat.comTop Incyte Executive Cashes In on Stock Sale!October 6, 2025 | tipranks.comMaze Therapeutics Appoints Hervé Hoppenot as Chairman of the Board of DirectorsOctober 6, 2025 | quiverquant.comQGrimes & Company Inc. Has $12.26 Million Position in Incyte Corporation $INCYOctober 6, 2025 | marketbeat.comWall Street Zen Upgrades Incyte (NASDAQ:INCY) to "Strong-Buy"October 6, 2025 | americanbankingnews.comLegacy Trust Cuts Holdings in Incyte Corporation $INCYOctober 5, 2025 | marketbeat.com14,665 Shares in Incyte Corporation $INCY Acquired by Strid Group LLCOctober 5, 2025 | marketbeat.comLGT Fund Management Co Ltd. Buys Shares of 52,200 Incyte Corporation $INCYOctober 4, 2025 | marketbeat.comImpact Investors Inc Has $209,000 Stock Position in Incyte Corporation $INCYOctober 4, 2025 | marketbeat.comIncyte (NASDAQ:INCY) Raised to "Strong-Buy" at Wall Street ZenOctober 3, 2025 | marketbeat.comIncyte Appoints Thomas Tray as Financial OfficerOctober 3, 2025 | tipranks.comIncyte (NASDAQ:INCY) Hits New 1-Year High - Here's What HappenedOctober 2, 2025 | marketbeat.comRobeco Institutional Asset Management B.V. Has $162.51 Million Stock Position in Incyte Corporation $INCYOctober 2, 2025 | marketbeat.comIncyte (INCY) Price Target Lifted on CALR Antibody Program OptimismOctober 2, 2025 | msn.comLbp Am Sa Has $12.17 Million Stock Position in Incyte Corporation $INCYOctober 1, 2025 | marketbeat.comPublic Employees Retirement System of Ohio Buys 3,951 Shares of Incyte Corporation $INCYOctober 1, 2025 | marketbeat.comIncyte Corp. stock underperforms Tuesday when compared to competitors despite daily gainsSeptember 30, 2025 | marketwatch.comNew Bill: Representative Michael Lawler introduces H.R. 5435: Stop CMV Act of 2025September 30, 2025 | quiverquant.comQCoach achieves remission chemo-free in follicular lymphoma trialSeptember 30, 2025 | usatoday.comPoinciana Advisors Group LLC Makes New Investment in Incyte Corporation $INCYSeptember 30, 2025 | marketbeat.comPatton Albertson Miller Group LLC Acquires 5,497 Shares of Incyte Corporation $INCYSeptember 28, 2025 | marketbeat.comPatton Fund Management Inc. Takes $254,000 Position in Incyte Corporation $INCYSeptember 28, 2025 | marketbeat.comChina Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD IndicationSeptember 27, 2025 | globenewswire.comAugustine Asset Management Inc. Makes New Investment in Incyte Corporation $INCYSeptember 27, 2025 | marketbeat.comIncyte (INCY) Advances Clinical Trials for Povorcitinib Across Multiple ConditionsSeptember 27, 2025 | insidermonkey.comJim Cramer Calls Incyte “Way Too Cheap”September 25, 2025 | finance.yahoo.comRuffer LLP Sells 9,988 Shares of Incyte Corporation $INCYSeptember 25, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Has $5.67 Million Stock Holdings in Incyte Corporation $INCYSeptember 25, 2025 | marketbeat.comIs Incyte Stock Outperforming the S&P 500?September 24, 2025 | finance.yahoo.comIncyte price target raised to $81 from $72 at RBC CapitalSeptember 24, 2025 | msn.com Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INCY Media Mentions By Week INCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INCY News Sentiment▼0.830.75▲Average Medical News Sentiment INCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INCY Articles This Week▼2326▲INCY Articles Average Week Get the Latest News and Ratings for INCY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Incyte and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AbbVie News Today Regeneron Pharmaceuticals News Today Alnylam Pharmaceuticals News Today Biogen News Today United Therapeutics News Today Neurocrine Biosciences News Today Ionis Pharmaceuticals News Today Exelixis News Today Exact Sciences News Today BioMarin Pharmaceutical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INCY) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Incyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
